A 3-year-old boy from rural Maharashtra presents with recurrent episodes of hypoglycemia, lethargy, and hepatomegaly. His mother reports that symptoms worsen during fasting or intercurrent illness. Serum glucose is 45 mg/dL during a fasting episode. Liver biopsy shows hepatic steatosis. Plasma carnitine levels are markedly reduced (0.2 mmol/L; normal 40–50 mmol/L). Urine organic acids show elevated dicarboxylic acids. What is the primary biochemical defect underlying this clinical presentation?

Explanation

## Clinical Diagnosis: Primary Carnitine Deficiency ### Pathophysiology This child has **primary carnitine deficiency** due to mutations in the SLC22A5 gene encoding the carnitine transporter OCTN2. This transporter is essential for renal reabsorption and cellular uptake of carnitine. **Key Point:** In primary carnitine deficiency, plasma carnitine is profoundly low (typically < 5 µmol/L), whereas in secondary deficiencies (CPT I/II, ACAD defects), plasma carnitine is normal or elevated. ### Why This Patient Fits Primary Carnitine Deficiency | Feature | Primary Carnitine Deficiency | Secondary Deficiencies | |---------|------------------------------|------------------------| | **Plasma carnitine** | Markedly ↓ (< 5 µmol/L) | Normal or ↑ | | **Urine carnitine** | ↓ (renal wasting) | Variable | | **Dicarboxylic acids** | Present (incomplete β-oxidation) | Present | | **Hepatomegaly** | Yes (fatty infiltration) | Yes | | **Hypoketotic hypoglycemia** | Yes | Yes | **High-Yield:** The markedly reduced plasma carnitine (0.2 mmol/L) is the diagnostic hallmark. CPT I/II deficiencies and ACAD defects cause secondary carnitine depletion, but plasma carnitine remains normal or elevated because the transport defect is absent. ### Biochemical Mechanism Carnitine is essential for transporting long-chain fatty acyl-CoA across the inner mitochondrial membrane via the CPT shuttle. Without adequate carnitine: 1. Fatty acid oxidation is severely impaired 2. Acetyl-CoA production drops → hypoglycemia (no gluconeogenic substrate) 3. Unoxidized fatty acyl-CoA accumulates → hepatic steatosis 4. Incomplete oxidation produces dicarboxylic acids (excreted in urine) **Clinical Pearl:** Hypoketotic hypoglycemia (low glucose with inappropriately low ketones) is pathognomonic for disorders of fatty acid oxidation — the body cannot mobilize fat for energy. ### Management Oral L-carnitine supplementation (100–400 mg/kg/day) completely reverses the metabolic derangement and prevents recurrent hypoglycemic episodes. **Mnemonic: CARNITINE DEFICIENCY = "CAN'T" transport fatty acids** - **C**arnitine levels ↓↓ - **A**cetyl-CoA ↓ (no fuel) - **N**o ketones (hypoketotic) - **T**ransporter (SLC22A5) defective [cite:KD Tripathi 8e Ch 18]